In search of real-world cerebroprotection: An institutional perspective and review of the literature

探寻现实世界中的脑保护:机构视角及文献综述

阅读:1

Abstract

PurposeIntravenous (IV) thrombolysis and mechanical thrombectomy remain the only interventions shown to improve outcomes in acute ischemic stroke. This study evaluated the impact of commonly administered intraprocedural medications, each with putative neuroprotective mechanisms backed up by basic science literature, on outcomes in mechanical thrombectomy for acute ischemic stroke.Methods and ResultsA retrospective review of 284 patients utilizing univariate and multivariate analysis evaluated associations between administration of IV/intra-arterial (IA) tissue plasminogen activator (tPA), IV/IA heparin and IA verapamil as well as key outcomes: recanalization success, postoperative hemorrhage, and 90-day functional status. None of these medications were associated with favorable recanalization (TICI 2b/3) or functional outcomes (90-day modified Rankin score 0-2). IV tPA was associated with decreased rates of periprocedural hemorrhage (OR = 0.506, 95% CI [0.255-0.980], p = 0.046). Successful recanalization (OR = 2.22, 95% CI [1.03-.4.98], p = 0.046), presence of any hemorrhage (OR = 0.27, 95% CI [0.14-0.51], p = <0.001), lower age and lower NIHSS, were predictive of good outcome. Heparin was associated with an increased risk of hemorrhage (OR = 1.90, 95% CI [1.11-3.21], p = 0.02) and poorer outcomes (OR = 0.56, 95% CI [0.35-0.91], p = 0.018) in univariate analysis, with a similar trend in multivariate analysis (OR 0.57, 95% CI [0.30-1.06] p = 0.079).ConclusionAlthough several medications with basic science support for cerebroprotective effects are frequently administered during thrombectomy, the most effective strategies for improving functional outcomes remain prompt, successful recanalization and minimizing hemorrhage. With recanalization rates exceeding 80% and primarily determined by mechanical factors, targeting hemorrhage reduction appears critical for further outcome improvements. Evidence linking post-ischemic hemorrhage to blood-brain barrier disruption offers future avenues for research into interventions for this potentially reversible process.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。